Clinical Trial Update: Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics [Phase 3]

View source ↗

Summary

Phase 3 trial comparing alogliptin to glipizide in elderly patients with diabetes, assessing efficacy and safety; results completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Glipizide (Glipizide)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-05-24